ライフサイエンスコーパス: n

1 IOP following washout for patients using 0 (n = 100), 1 (n = 705), 2 (n = 355), 3 (n = 214), or 4 (n

2 (11 424/16 346 [69.9%]) and, overall, 67.0% (n = 11 033) had an underlying comorbidity.

3 g washout for patients using 0 (n = 100), 1 (n = 705), 2 (n = 355), 3 (n = 214), or 4 (n = 26) medica

4 Cohort 1 (n = 24,475) was examined during 1971 to 1991 and followe

5 active control at 6-month follow-up (k = 10; n = 738; SMD = -0.45, 95% CI -0.82 to -0.08).

6 t year postpartum, 64% (n = 19,344) and 13% (n = 3,994) did not migrate and resided within and outsid

7 cted 29 (41%) patients over five years; 16% (n=14) of infections had mixed-strains.

8 urgery was performed within 24 hours in 18% (n = 180), within 48 hours in 20.6% (n = 203), within 72

9 nts with chronic liver disease and COVID-19 (n = 375), incidence of acute liver injury was lower in L

10 patients using 0 (n = 100), 1 (n = 705), 2 (n = 355), 3 (n = 214), or 4 (n = 26) medications was 0.2

11 Group 2 (n=30) were treated with the same schedule and had sparse

12 For children alive in 2015 (n = 13,729,000), this would avert 240,000 (95% UI 65,000

13 ng 0 (n = 100), 1 (n = 705), 2 (n = 355), 3 (n = 214), or 4 (n = 26) medications was 0.2 (2.8), 5.7 (

14 Mortality rate was 22.3% (n = 25); 72.3% (n = 81) were hospitalized and 26.8% (n =

15 tive in 42% (n = 231) and negative in 57.3% (n = 311).

16 Mortality rate was 22.3% (n = 25); 72.3% (n = 81) were hospitalized and 26.8% (n = 30) admitted to

17 majority underwent excisional biopsy (55.3%, n = 302/546) or lumpectomy (wide excision) (38.5%, n = 2

18 the formula (A')(2) (A)(n) (-1) Pb(n) I(3) (n) (+1) have remarkable stability and promising efficien

19 1 (n = 705), 2 (n = 355), 3 (n = 214), or 4 (n = 26) medications was 0.2 (2.8), 5.7 (3.3), 6.9 (3.7),

20 Surgical margins were positive in 42% (n = 231) and negative in 57.3% (n = 311).

21 symptoms more than inactive control (k = 46; n = 3,389; standardised mean difference [SMD] = -0.82, 9

22 2/546) or lumpectomy (wide excision) (38.5%, n = 210/546).

23 nt in domestic cat versus domestic dog (51%, n = 32 of 62 cats; 15%, 11 of 70 dogs were positive for

24 in 18% (n = 180), within 48 hours in 20.6% (n = 203), within 72 hours in 21.7% (n = 214), and within

25 .7% (n = 214), and within 96 hours in 22.6% (n = 223) of the appointment.

26 (n = 571) intended to be vaccinated, 31.6% (n = 313) were not sure, and 10.8% (n = 107) did not inte

27 The incidence of LARS was 82.6% (n = 109/132), which was minor in 26/132 (19.7%) and majo

28 The triads, BTMPA-Im->AlPorF(n)-Ph-C(60) (n = 0, 3, 5), were constructed by linking the fullerene

29 regnancy and the first year postpartum, 64% (n = 19,344) and 13% (n = 3,994) did not migrate and resi

30 CA represented 1.7% (n=65 033) of the total PCI volume.

31 LD-Na resulted in reclassification of 16.7% (n = 672) of patients on the WL.

32 n 20.6% (n = 203), within 72 hours in 21.7% (n = 214), and within 96 hours in 22.6% (n = 223) of the

33 d, 31.6% (n = 313) were not sure, and 10.8% (n = 107) did not intend to be vaccinated.

34 72.3% (n = 81) were hospitalized and 26.8% (n = 30) admitted to the intensive care unit (ICU).

35 CI] -1.02 to -0.63) and active control (k-9; n = 662; SMD = -0.35, 95% CI -0.56 to -0.14) at posttrea

36 TX plus nelarabine, had a 5-year DFS of 91% (n = 147).

37 ide perovskites with the formula (A')(2) (A)(n) (-1) Pb(n) I(3) (n) (+1) have remarkable stability an

38 ng of asymptomatic laboratory abnormalities (n = 4), hepatitis and colitis (n = 2).

39 and TBI patients (categories 2 and 3 above, n = 59/148).

40 Omega-3 fatty acids (n-3 PUFAs) are essential for the functional maturation o

41 dy with a total of 857 subjects from the AD (n = 213), MCI (n = 322), and control (CN, n = 322) group

42 st prices of noninsulin antidiabetic agents (n = 10) increased by 165%, and net prices decreased by 1

43 icogram level can be easily achieved for all n-alkanes.

44 CI: 3.1 to 13.6) for TLNB followed by ALND (n = 203) and 4.3% (2 of 46, 95% CI: 0.5 to 14.8) for TAD

45 % CI: 0.5 to 14.8) for TAD followed by ALND (n = 77).

46 ol (n = 720) or the standard protocol alone (n = 773).

47 r metastases assigned to (177)Lu-PSMA alone (n = 31) or in combination with SIRT (n = 5) were retrosp

48 The triads, BTMPA-Im->AlPorF(n)-Ph-C(60) (n = 0, 3, 5), were constructed by linking t

49 ly, the lifetime of the BTMPA(*+)-Im->AlPorF(n)-Ph-C(60)(*-) radical pair was found to be very differ

50 umors harbored FGFR1 or FGFR2 amplification (n = 20), FGFR2 or FGFR3 single-nucleotide variants (n =

51 of depression cases, 2 of which (n = 38 and n = 100; 67% collectively) were associated with increase

52 rotein-treated controls (1012 vg per animal, n = 10 per group) with PHP.B vectors.

53 pectroscopy shows the presence of [Ga(arene)(n) ](+) salts on oxidation of Ga metal with AgOTf in are

54 double-blind RCT and randomized into 4 arms (n = 23): HP-diet and beta-cryptoxanthin (hypocaloric HP-

55 nd combined chylothorax and chylous ascites (n = 4; 16%).

56 ignificantly associated with incident ASCVD (n = 1386 events; median follow-up, 25.2 years; hazard ra

57 d dyads were enrolled and randomly assigned (n=376 group-only intervention, n=400 mixed-delivery inte

58 imized parameters, to each polymorphic AT1R (n = 6).

59 utoimmune hepatitis related to atezolizumab [n=1] and septic shock related to nab-paclitaxel [n=1]) a

60 esection and intestinal autotransplantation (n = 12), ex vivo Whipple procedure and liver autotranspl

61 ple procedure and liver autotransplantation (n = 8) and multivisceral ex vivo procedure (n = 7).

62 tobiprole (n = 335) or vancomycin/aztreonam (n = 344).

63 selected on a first-come first-served basis (n = 130; M age = 45.8, SD = 8; M BMI = 34.48 kg/m2, SD =

64 ly injections of either 1.25 mg bevacizumab (n = 86) or 0.5 mg ranibizumab (n = 84).

65 racteristics were equal between bivalirudin (n=799) and heparin (n=793) treated patients >=75 years.

66 Despite blacks (n = 407) reporting higher levels of medical mistrust (40

67 umour bed boost (n=605) or tumour bed boost (n=603).

68 mly assigned to receive no tumour bed boost (n=605) or tumour bed boost (n=603).

69 d unusual yellow discoloration of the bowel (n = 3) and bowel infarction (n = 2).

70 erformed metabolite profiling in both brain (n = 109) and matching serum samples (n = 566) to identif

71 In 3 collections of human postmortem brain (n = 206) and 1 collection of blood samples (N = 1132) of

72 is explored for the {WTp(NO)(PBu(3))} (Bu = n-butyl; Tp = trispyrazoylborate) system as a function o

73 matched patients with svPPA (n = 70), bvFTD (n = 70) and Alzheimer's disease (n = 70).

74 the signal and associated response slope by n times.

75 slipping dynamics and conformations of (CAG)n TR hairpins.

76 sociation analysis of MD (n = 135,458 cases, n = 344,901 controls) and gene expression levels from 21

77 th 25.0-37.5% of deaths from medical causes (n = 8).

78 79 patients were randomized to ceftobiprole (n = 335) or vancomycin/aztreonam (n = 344).

79 Long-chain n-3 PUFAs (n-3 LCPUFAs) accrete in the brain during chil

80 Indications were chylothorax (n = 19; 76%), cervical lymphatic fistula (n = 2; 8%), an

81 ents; HR, 0.91 [95% CI, 0.76-1.09]), or CKD (n = 2433 events; HR, 0.98 [95% CI, 0.65-1.11]).

82 D (n = 213), MCI (n = 322), and control (CN, n = 322) groups, we used structural MRI data and neurops

83 With a training cohort (n = 40) and a blinded validation cohort (n = 90) acquire

84 rt (n = 40) and a blinded validation cohort (n = 90) acquired from CDC, the Lyme Immunochip identifie

85 bnormalities (n = 4), hepatitis and colitis (n = 2).

86 Cases of microscopic colitis (n= 13,957) were identified through Systematized Nomencla

87 local (n= 6), distant (n = 3), and combined (n = 3)-at a median of 9.8 months from diagnosis (range,

88 to difficulties in integrating complementary n- and p-channel transistors in a common quantum dot act

89 olated from hindlimb muscle of control (CON, n = 11-12) and IUGR (n = 12) late gestation fetal sheep.

90 andomized into exercise (n = 23) or control (n = 22) groups.

91 ne before the intervention in 2014 (control: n = 1,301, intervention: n = 1,357), the other 2 years a

92 e other 2 years afterwards in 2016 (control: n = 996, intervention: n = 1,035).

93 Disorder (MDD) (n = 64) to healthy controls (n = 64) using a comprehensive battery of nine value-base

94 euritis (n=5) and non-neurological controls (n=37).

95 28-60 years), healthy individuals (controls, n = 24), mice, and rats.

96 ed n(Hill) ~2.9, near maximal cooperativity (n(Hill) = 4).

97 Surgical correlation (n = 4) revealed unusual yellow discoloration of the bowe

98 ry in HIV-infected adults with cryptococcal (n = 31) and noncryptococcal (n = 12) meningitis and in h

99 splant; and the Cross sectional Cohort (CSC, n=446): patients developing new-onset renal function det

100 s examined with patient sera (n = 31), CSFs (n = 11), longitudinal serum samples (n = 15), and using

101 e 960 mg of oral co-trimoxazole twice daily (n = 170) or matched placebo (n = 172) for between 12 and

102 lysis of publicly available microarray data (n = 303 profiles) measured in livers of fathead minnows

103 ap by fitting a computational model to data (n = 1754) from a modified serial dictator game, to explo

104 with infusion of terlipressin (2-12 mg/day; n = 60) or noradrenaline (0.5-3.0 mg/h; n = 60).

105 123), other types of dementia (n.

106 planted mice were treated with vehicle or di-n-butyl-phthalate (DBP, a plasticising chemical known to

107 nd individuals with prediabetes or diabetes (n = 8/group).

108 70), bvFTD (n = 70) and Alzheimer's disease (n = 70).

109 collected from healthy (n = 5) and diseased (n = 5) sites of each patient.

110 s experienced relapse-local (n= 6), distant (n = 3), and combined (n = 3)-at a median of 9.8 months f

111 0.655) in those who had received >=15 doses (n=20).

112 in the patients who had received <15 doses (n=34), and -0.0135+/-0.1332 (not significantly different

113 Diabetic eyes without DR (n = 138) and eyes with mild/moderate nonproliferative DR

114 common therapeutic needs involved new drugs (n = 149, 51.0%), cell regeneration (n = 115, 39.4%), and

115 ceived anti-VEGF therapy according to a T&E (n = 163) or PRN (n = 101) regimen.

116 y) (n = 20); AgP+CS/EMD (n = 20); CP+CS/EMD (n = 20).

117 (conservative surgery) (n = 20); AgP+CS/EMD (n = 20); CP+CS/EMD (n = 20).

118 students diagnosed to have refractive error (n = 92), myopia constituted 83/92 (90.2%) of the student

119 ls in the United States (n = 13) and Europe (n = 3).

120 omen (n = 45) were randomized into exercise (n = 23) or control (n = 22) groups.

121 umor biopsies positive for PD-L1 expression (n = 28/40 evaluable), and response rates were higher in

122 eline vision (n = 2), stable mild exudation (n = 1), and progressive vasoproliferation with traction

123 ily netarsudil 0.02%/latanoprost 0.005% FDC (n = 238), netarsudil 0.02% only (n = 243), or latanopros

124 method to detect patients with fibromyalgia (n = 252, 126 controls and 126 patients with fibromyalgia

125 x (n = 19; 76%), cervical lymphatic fistula (n = 2; 8%), and combined chylothorax and chylous ascites

126 For n = 18 inpatients (78.26%) hospitalised for at least 7 d

127 ariants (n = 19), or FGFR1 or FGFR3 fusions (n = 9).

128 adsorption coefficients of 156 and 629 L/g(-n), respectively.

129 s application in high-performance back-gated n-type MoS(2) and p-type WSe(2) transistors with sub-thr

130 TIE, only 3.6 mL of residues was generated (n = 12) over 60-240 mL in reference methods (n = 3).

131 confined to the dorsal portion of the gland (n = 161), also demonstrated UDD to be a significant pred

132 = 26) and 225 nontransplant recipients (GNB n = 114; SAB n = 111) were included for clinical analysi

133 Fifty-five transplant recipients (GNB n = 29; SAB n = 26) and 225 nontransplant recipients (GN

134 onths (10.4-15.0) in the chemotherapy group (n=207; hazard ratio 0.89, 95% CI 0.71-1.11; p=0.30).

135 In the public setting, the non-JADE group (n = 3,587) underwent structured evaluation for risk fact

136 4-17.3) in the durvalumab monotherapy group (n=209) versus 12.1 months (10.4-15.0) in the chemotherap

137 BV patients were randomized to four groups (n = 17/group) after seven-day oral metronidazole treatme

138 consenting patients (50 Gy, n = 937; 40 Gy, n = 917) were enrolled from 2009-2014 from eight centers

139 A total of 1,854 consenting patients (50 Gy, n = 937; 40 Gy, n = 917) were enrolled from 2009-2014 fr

140 day; n = 60) or noradrenaline (0.5-3.0 mg/h; n = 60).

141 ped 2D perovskite (HA)(2) (GA)Pb(2) I(7) (HA=n-hexylammonium, GA=guanidinium).

142 nt, GCF samples were collected from healthy (n = 5) and diseased (n = 5) sites of each patient.

143 ual between bivalirudin (n=799) and heparin (n=793) treated patients >=75 years.

144 performed procedure was ex vivo hepatectomy (n = 18), followed by ex vivo resection and intestinal au

145 d ratio [HR], 1.06 [95% CI, 0.89-1.26]), HF (n = 1396 events; HR, 0.91 [95% CI, 0.76-1.09]), or CKD (

146 onal study evaluated 6 individuals with HIV (n = 4 with viral suppression using antiretroviral [ART]

147 ts] and 1.02 [95% CI, 0.92-1.14] in CLUE II [n = 1497 events]).

148 n of the bowel (n = 3) and bowel infarction (n = 2).

149 thy control subjects with neither infection (n = 10).

150 requent pathophysiologies were inflammation (n = 104, 35.6%) related to sepsis, respiratory failure,

151 organ dysfunction; and direct tissue injury (n = 64, 21.9%) including brain and spinal cord trauma.

152 eriod of the limit cycles becomes an integer n > 1 multiple of the driving period.

153 rvention, n=400 mixed-delivery intervention, n=376 comparison group).

154 mly assigned (n=376 group-only intervention, n=400 mixed-delivery intervention, n=376 comparison grou

155 n in 2014 (control: n = 1,301, intervention: n = 1,357), the other 2 years afterwards in 2016 (contro

156 rds in 2016 (control: n = 996, intervention: n = 1,035).

157 ate the effects of perioperative intravenous n-3 PUFAs on inflammatory cytokines in colon cancer surg

158 tients were included in the group with ITBA (n = 10 of 35; 28.6%), and 25 patients were included in t

159 muscle of control (CON, n = 11-12) and IUGR (n = 12) late gestation fetal sheep.

160 tors and complications only, while the JADE (n = 9,601) group received a JADE report with group empow

161 rapy (n = 36) versus treatment waiting list (n = 30).

162 ns in polynomial time and guarantees an O(ln n) approximation.

163 Twelve patients experienced relapse-local (n= 6), distant (n = 3), and combined (n = 3)-at a median

164 4 sunscreen products, formulated as lotion (n = 12), aerosol spray (n = 12), nonaerosol spray (n = 1

165 MXenes (M(n+1)X(n)) have two sites for compositional variation: el

166 inal serum samples (n = 15), and using mAbs (n = 14) generated from peripheral B cells of two patient

167 of 857 subjects from the AD (n = 213), MCI (n = 322), and control (CN, n = 322) groups, we used stru

168 gest genome-wide association analysis of MD (n = 135,458 cases, n = 344,901 controls) and gene expres

169 gnosed with Major Depressive Disorder (MDD) (n = 64) to healthy controls (n = 64) using a comprehensi

170 n = 12) over 60-240 mL in reference methods (n = 3).

171 The pK(a)(MeCN)([MHL(n)](+)/[ML(n)) of paramagnetic hydrides in MeCN are esti

172 Ten weeks old male C57BL/6 mice (n = 9) underwent left anterior descending (LAD) coronary

173 C57BL/6J female mice (n = 18) were first treated with antibiotics for 4 weeks

174 detection limit was calculated as 22 ng/mL (n = 6) using the 3 Sb/m formula.

175 The pK(a)(MeCN)([MHL(n)](+)/[ML(n)) of paramagnetic hydrides in MeCN are estimated for t

176 onth 24, the mean IOP was 12.6 +/- 4.4 mmHg (n = 29, P = 0.519) on 2.0 +/- 1.6 (P = 0.457) glaucoma m

177 4%), and immune and inflammatory modulation (n = 79, 27.1%).

178 f nicotine replacement therapy at 12 months (n = 257; 8.1% vs 8.2%).

179 Accurate mass and tandem multistage MS (MS(n)) were used for structure identification of vaping pro

180 tides using multistage mass spectrometry (MS(n)).

181 MOG-Ab-serostatus), multiple sclerosis (MS) (n=69), optic neuritis (n=5) and non-neurological control

182 polarization (half-widths: 0.25 +/- 0.08 ms, n = 19 wild-type, 0.60 +/- 0.17 ms, n = 21 Kv3.3KO, p =

183 0.08 ms, n = 19 wild-type, 0.60 +/- 0.17 ms, n = 21 Kv3.3KO, p = 0.0001).

184 Z heterozygotes confirmed by sequencing (MZ; n = 74) had lower post-bronchodilator FEV(1) (P = 0.007)

185 e 1,089 CHB patients, classified as no-NASH (n = 904, 83%) or NASH (n = 185, 17%), with 52 (6%) versu

186 lassified as no-NASH (n = 904, 83%) or NASH (n = 185, 17%), with 52 (6%) versus 27 (15%) experiencing

187 tiple sclerosis (MS) (n=69), optic neuritis (n=5) and non-neurological controls (n=37).

188 were 1.17 [95% CI, 0.87-1.56] in the NHANES [n = 1012 events] and 1.02 [95% CI, 0.92-1.14] in CLUE II

189 re measured by ELISA in patients with NMOSD (n=39, 28 aquaporin-4 (AQP4)-Ab-seropositive, 3 double-Ab

190 h cryptococcal (n = 31) and noncryptococcal (n = 12) meningitis and in heathy control subjects with n

191 oliferative DR (NPDR; n = 125), severe NPDR (n = 20), and proliferative DR (PDR; n = 72) were include

192 ith mild/moderate nonproliferative DR (NPDR; n = 125), severe NPDR (n = 20), and proliferative DR (PD

193 eriments to determine the respective CMCs of n-octyl beta-d-glucopyranoside (OG), n-dodecyl beta-d-ma

194 ient of K(d) ~16 muM and Hill coefficient of n ~2.

195 The combination of n electrodes, demonstrating individually a Nernstian slo

196 Serum concentrations of n-3 PUFAs were significantly higher in the DE and DP gro

197 ied neuroimaging in a longitudinal sample of n = 146 participants aged 12-30.

198 not, leading to the creation of a W state of n + m - 2 electrons in the successful case.

199 The enthalpy of vaporization of n-eicosane at 359.0 K was calculated to be Delta(vap)H =

200 CMCs of n-octyl beta-d-glucopyranoside (OG), n-dodecyl beta-d-maltopyranoside (DDM), and lauryldimeth

201 only (n = 243), or latanoprost 0.005% only (n = 237).

202 0.005% FDC (n = 238), netarsudil 0.02% only (n = 243), or latanoprost 0.005% only (n = 237).

203 and septic shock related to nab-paclitaxel [n=1]) and one (<1%) patient in the placebo group (hepati

204 e PreCARE cohort of pregnant women in Paris (n = 9,579).

205 th survey taken by a subset of participants (n = 157,366) in the UK Biobank.

206 Overall, 57.6% of participants (n = 571) intended to be vaccinated, 31.6% (n = 313) were

207 In PESA participants (n = 4,184 subjects free of cardiovascular disease), PA w

208 When 25% participated (n = 101), there was a 9.1% relative reduction in inciden

209 Patients (n=448) were randomized 1:1:1 to placebo, 25 mg of OM BID

210 A total of 111 eligible patients (n(implants) = 501) were assessed.

211 edictive tool for graft failure in patients (n = 181) who received a kidney transplant in Olmsted Cou

212 fected cells, whereas PV from IRI- patients (n = 32) primarily increased hTLR7 and hNOD2 activation.

213 in (an inflammatory marker) in MWA patients (n = 11) who experienced headaches and visual aura in the

214 A subset of patients (n = 116) enrolled in 3 phase-3 randomized clinical trial

215 Thirteen percent of patients (n = 5) had treatment-related grade 3 or 4 adverse events

216 A subset of patients (n = 98) were selected for a WES-only pipeline if the his

217 otopic liver transplantation (OLT) patients (n = 35) decreased activation of hTLR4- and hTLR9-transfe

218 ites with the formula (A')(2) (A)(n) (-1) Pb(n) I(3) (n) (+1) have remarkable stability and promising

219 were evaluated: The Prospective Cohort (PC, n=581): Patients undergoing first for cause kidney biops

220 re NPDR (n = 20), and proliferative DR (PDR; n = 72) were included.

221 for the next generation of high-performance n-type materials for thermoelectric applications.

222 iferation with traction leading to phthisis (n = 2).

223 le twice daily (n = 170) or matched placebo (n = 172) for between 12 and 42 months.

224 s 28 days apart (20 ug, n = 201) or placebo (n = 199) and were followed up for 72 weeks.

225 150 mg/d of resveratrol (n = 20) or placebo (n = 21) for 6 mo.

226 [n=1], and Pneumocystis jirovecii pneumonia [n=1]).

227 therapy according to a T&E (n = 163) or PRN (n = 101) regimen.

228 (n = 8) and multivisceral ex vivo procedure (n = 7).

229 ively, local heating MoS(2) in N(2) produces n-character.

230 blue visual HPTs plus the standard protocol (n = 720) or the standard protocol alone (n = 773).

231 Long-chain n-3 PUFAs (n-3 LCPUFAs) accrete in the brain during childhood and a

232 ative vitreoretinopathy (PVR) (n = 30), PVR (n = 16) and proliferative diabetic retinopathy (PDR) wit

233 thout proliferative vitreoretinopathy (PVR) (n = 30), PVR (n = 16) and proliferative diabetic retinop

234 ed through a one-pot reaction using [Ag(pz)](n) as precursor (Hpz=pyrazole) and further characterized

235 Coenzyme Q (Q (n) ) is a vital lipid component of the electron transpor

236 uration indicated a higher contribution to R(n).

237 bevacizumab (n = 86) or 0.5 mg ranibizumab (n = 84).

238 First impression ratings (n = 227) of Barbary macaques' social and health traits w

239 abetic retinopathy (PDR) with tractional RD (n = 8).

240 oup (sepsis [n=2], hepatitis B reactivation [n=1], and Pneumocystis jirovecii pneumonia [n=1]).

241 w drugs (n = 149, 51.0%), cell regeneration (n = 115, 39.4%), and immune and inflammatory modulation

242 hin canine mammary tumor associated regions (n = 471).

243 prescribing in all analyses; the remainder (n = 6) had a mix of positive and null findings.

244 d to receive either 150 mg/d of resveratrol (n = 20) or placebo (n = 21) for 6 mo.

245 Rhesus macaques (RMs) (n = 13) were infected with simian/human immunodeficiency

246 Intra- and inter-day RSD% (n = 3) at two concentration levels of 25 and 250 ug L(-1

247 hing the reversible potassium sulfide K(2) S(n) phase sequence, the parasitic polysulfide shuttle, pu

248 5 nontransplant recipients (GNB n = 114; SAB n = 111) were included for clinical analysis.

249 -five transplant recipients (GNB n = 29; SAB n = 26) and 225 nontransplant recipients (GNB n = 114; S

250 , CSFs (n = 11), longitudinal serum samples (n = 15), and using mAbs (n = 14) generated from peripher

251 brain (n = 109) and matching serum samples (n = 566) to identify differentially expressed metabolite

252 ) and four in the intravenous group (sepsis [n=2], hepatitis B reactivation [n=1], and Pneumocystis j

253 recognition was examined with patient sera (n = 31), CSFs (n = 11), longitudinal serum samples (n =

254 ling code from 2010 to 2017: a training set (n=886), an internal validation set from site no.

255 o a training (n = 318) and a validation set (n = 189).

256 cal and isotopic analysis of ceramic sherds (n = 125) from Pastoral Neolithic archaeological contexts

257 alone (n = 31) or in combination with SIRT (n = 5) were retrospectively analyzed.

258 ormulated as lotion (n = 12), aerosol spray (n = 12), nonaerosol spray (n = 12), and pump spray (n =

259 ), aerosol spray (n = 12), nonaerosol spray (n = 12), and pump spray (n = 12).

260 , nonaerosol spray (n = 12), and pump spray (n = 12).

261 16 teaching hospitals in the United States (n = 13) and Europe (n = 3).

262 ted genes were either from human BC studies (n = 294) or from within canine mammary tumor associated

263 Twenty-five studies (n = 15 785) evaluated the accuracy of screening tests; a

264 Most studies (n = 30) identified a positive association between paymen

265 e original methods in a multinational study (n = 4,098 participants, 19 countries, 13 languages), adj

266 In COPD (SPIROMICS) bronchoscopy sub-study (n = 195).

267 global visual processing in human subjects (n = 10) was correlated with the fMRI response evoked by

268 Supplemental n-3 FAs did not significantly reduce the primary cardiov

269 ients who underwent tricuspid valve surgery (n = 344), a post-operative improvement in MELD-XI score

270 three groups: AgP+CS (conservative surgery) (n = 20); AgP+CS/EMD (n = 20); CP+CS/EMD (n = 20).

271 th age- and sex-matched patients with svPPA (n = 70), bvFTD (n = 70) and Alzheimer's disease (n = 70)

272 (NRs), NR2F2 and NR2C2, can bind to (TCAGGG)(n) variant repeats within telomeres and it has been prop

273 were split into training (n = 97) and test (n = 49) cohorts.

274 HLHS/TGA (n = 24), CHD-other (50), and CHD-related (34) groups eac

275 hereas Ni(4+) and Fe(3+) are observed in the n = 5 superlattice.

276 atients with infectious complications in the n-3 PUFA group (8 compared with 3, P = 0.036).

277 incorporation by PrimPol is dependent on the n-1 nucleotide.

278 Holding m = 1, spectroscopy reveals that the n = 1 superlattice contains Ni(3+) and Fe(4+) , whereas

279 During external validation, the n-gram model demonstrated good discrimination between ac

280 linical trial of prolonged exposure therapy (n = 36) versus treatment waiting list (n = 30).

281 pression using antiretroviral [ART] therapy; n = 2 with rebound viremia after stopping ART), who prov

282 red seven PLWH were divided into a training (n = 318) and a validation set (n = 189).

283 ember 2017 and who were split into training (n = 97) and test (n = 49) cohorts.

284 y, a representative cohort of British twins (n = 2,232) followed across the first 2 decades of life.

285 tramuscular injections 28 days apart (20 ug, n = 201) or placebo (n = 199) and were followed up for 7

286 The mechanisms underlying n-3 PUFAs potential therapeutic properties remain unknow

287 , FGFR2 or FGFR3 single-nucleotide variants (n = 19), or FGFR1 or FGFR3 fusions (n = 9).

288 roliferation with return to baseline vision (n = 2), stable mild exudation (n = 1), and progressive v

289 sation in 2 trials of bupropion at 26 weeks (n = 523; 17% [300 mg] and 6% [150 mg] vs 10% [placebo];

290 4 subgroups of depression cases, 2 of which (n = 38 and n = 100; 67% collectively) were associated wi

291 ation (29.0% vs 15.7%, P < .01) than whites (n = 121), blacks were only slightly less likely than whi

292 On separate study days, adults with (n = 26) and without (n = 23) ADHD completed the bandit t

293 tudy days, adults with (n = 26) and without (n = 23) ADHD completed the bandit task at baseline, and

294 Obese, black South African women (n = 45) were randomized into exercise (n = 23) or contro

295 MXenes (M(n+1)X(n)) have two sites for compositional variation: elementa

296 PWA) device (Atcor Medical Sphygmocor XCEL) (n = 5) revealed central aortic systolic pulse (CASP) and

297 and 10-fold lower during the follow-up year (n = 18, P = .03).

298 In addition, in younger (4-6 years, n = 67), but not older (6-8 years, n = 70) children, hab

299 -6 years, n = 67), but not older (6-8 years, n = 70) children, habitual sleep duration was related to

300 ITC binding curves to the Hill model yielded n(Hill) ~2.9, near maximal cooperativity (n(Hill) = 4).